These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35568035)

  • 1. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
    Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
    Kimura I; Yamasoba D; Tamura T; Nao N; Suzuki T; Oda Y; Mitoma S; Ito J; Nasser H; Zahradnik J; Uriu K; Fujita S; Kosugi Y; Wang L; Tsuda M; Kishimoto M; Ito H; Suzuki R; Shimizu R; Begum MM; Yoshimatsu K; Kimura KT; Sasaki J; Sasaki-Tabata K; Yamamoto Y; Nagamoto T; Kanamune J; Kobiyama K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Shirakawa K; Takaori-Kondo A; Kuramochi J; Schreiber G; Ishii KJ; ; Hashiguchi T; Ikeda T; Saito A; Fukuhara T; Tanaka S; Matsuno K; Sato K
    Cell; 2022 Oct; 185(21):3992-4007.e16. PubMed ID: 36198317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48.
    Wang W; Jin Q; Liu R; Zeng W; Zhu P; Li T; Wang T; Xiang H; Zhang H; Chen Q; Gao Y; Lai Y; Yan F; Xia X; Li J; Wang X; Gao Y
    Front Immunol; 2024; 15():1427284. PubMed ID: 39411709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    Kimura I; Yamasoba D; Nasser H; Ito H; Zahradnik J; Wu J; Fujita S; Uriu K; Sasaki J; Tamura T; Suzuki R; Deguchi S; Plianchaisuk A; Yoshimatsu K; Kazuma Y; Mitoma S; Schreiber G; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Takaori-Kondo A; ; Ito J; Shirakawa K; Takayama K; Irie T; Hashiguchi T; Nakagawa S; Fukuhara T; Saito A; Ikeda T; Sato K
    J Virol; 2023 Oct; 97(10):e0101123. PubMed ID: 37796123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K
    Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
    Saito A; Tamura T; Zahradnik J; Deguchi S; Tabata K; Anraku Y; Kimura I; Ito J; Yamasoba D; Nasser H; Toyoda M; Nagata K; Uriu K; Kosugi Y; Fujita S; Shofa M; Monira Begum M; Shimizu R; Oda Y; Suzuki R; Ito H; Nao N; Wang L; Tsuda M; Yoshimatsu K; Kuramochi J; Kita S; Sasaki-Tabata K; Fukuhara H; Maenaka K; Yamamoto Y; Nagamoto T; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Ueno T; Schreiber G; Takaori-Kondo A; ; Shirakawa K; Sawa H; Irie T; Hashiguchi T; Takayama K; Matsuno K; Tanaka S; Ikeda T; Fukuhara T; Sato K
    Cell Host Microbe; 2022 Nov; 30(11):1540-1555.e15. PubMed ID: 36272413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike.
    Fang L; Kang X; Hong Q; Xue C; Pan L; Chen J; Tang C; Sun L; Xu X; Yuan J; Du Y; Xu A
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29716-29727. PubMed ID: 38814480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.
    Liu Y; Zhao X; Shi J; Wang Y; Liu H; Hu YF; Hu B; Shuai H; Yuen TT; Chai Y; Liu F; Gong HR; Li J; Wang X; Jiang S; Zhang X; Zhang Y; Li X; Wang L; Hartnoll M; Zhu T; Hou Y; Huang X; Yoon C; Wang Y; He Y; Zhou M; Du L; Zhang X; Chan WM; Chen LL; Cai JP; Yuan S; Zhou J; Huang JD; Yuen KY; To KK; Chan JF; Zhang BZ; Sun L; Wang P; Chu H
    Nat Commun; 2024 Oct; 15(1):8728. PubMed ID: 39379369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG
    J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
    Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.
    Uraki R; Kiso M; Iida S; Imai M; Takashita E; Kuroda M; Halfmann PJ; Loeber S; Maemura T; Yamayoshi S; Fujisaki S; Wang Z; Ito M; Ujie M; Iwatsuki-Horimoto K; Furusawa Y; Wright R; Chong Z; Ozono S; Yasuhara A; Ueki H; Sakai-Tagawa Y; Li R; Liu Y; Larson D; Koga M; Tsutsumi T; Adachi E; Saito M; Yamamoto S; Hagihara M; Mitamura K; Sato T; Hojo M; Hattori SI; Maeda K; Valdez R; ; Okuda M; Murakami J; Duong C; Godbole S; Douek DC; Maeda K; Watanabe S; Gordon A; Ohmagari N; Yotsuyanagi H; Diamond MS; Hasegawa H; Mitsuya H; Suzuki T; Kawaoka Y
    Nature; 2022 Jul; 607(7917):119-127. PubMed ID: 35576972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.
    Barut GT; Halwe NJ; Taddeo A; Kelly JN; Schön J; Ebert N; Ulrich L; Devisme C; Steiner S; Trüeb BS; Hoffmann B; Veiga IB; Leborgne NGF; Moreira EA; Breithaupt A; Wylezich C; Höper D; Wernike K; Godel A; Thomann L; Flück V; Stalder H; Brügger M; Esteves BIO; Zumkehr B; Beilleau G; Kratzel A; Schmied K; Ochsenbein S; Lang RM; Wider M; Machahua C; Dorn P; Marti TM; Funke-Chambour M; Rauch A; Widera M; Ciesek S; Dijkman R; Hoffmann D; Alves MP; Benarafa C; Beer M; Thiel V
    Nat Commun; 2022 Oct; 13(1):5929. PubMed ID: 36207334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
    Tamura T; Ito J; Uriu K; Zahradnik J; Kida I; Anraku Y; Nasser H; Shofa M; Oda Y; Lytras S; Nao N; Itakura Y; Deguchi S; Suzuki R; Wang L; Begum MM; Kita S; Yajima H; Sasaki J; Sasaki-Tabata K; Shimizu R; Tsuda M; Kosugi Y; Fujita S; Pan L; Sauter D; Yoshimatsu K; Suzuki S; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Yamamoto Y; Nagamoto T; Schreiber G; Maenaka K; ; Hashiguchi T; Ikeda T; Fukuhara T; Saito A; Tanaka S; Matsuno K; Takayama K; Sato K
    Nat Commun; 2023 May; 14(1):2800. PubMed ID: 37193706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
    Tamura T; Mizuma K; Nasser H; Deguchi S; Padilla-Blanco M; Oda Y; Uriu K; Tolentino JEM; Tsujino S; Suzuki R; Kojima I; Nao N; Shimizu R; Wang L; Tsuda M; Jonathan M; Kosugi Y; Guo Z; Hinay AA; Putri O; Kim Y; Tanaka YL; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Saito A; Ito J; Irie T; Tanaka S; Zahradnik J; Ikeda T; Takayama K; Matsuno K; Fukuhara T; Sato K
    Cell Host Microbe; 2024 Feb; 32(2):170-180.e12. PubMed ID: 38280382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage.
    Liang R; Ye ZW; Ong CP; Qin Z; Xie Y; Fan Y; Tang K; Poon VK; Chan CC; Yang X; Cao H; Wang K; Sun H; Hu B; Cai JP; Luo C; Chik KK; Chu H; Zheng Y; Yuen KY; Chan JF; Jin DY; Yuan S
    Emerg Microbes Infect; 2022 Dec; 11(1):2093-2101. PubMed ID: 35943779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
    Escalera A; Laporte M; Turner S; Karakus U; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Khalil Z; van Bakel H; Smith D; García-Sastre A; Aydillo T
    Emerg Microbes Infect; 2024 Dec; 13(1):2297553. PubMed ID: 38112266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.
    Xia S; Wang L; Jiao F; Yu X; Xu W; Huang Z; Li X; Wang Q; Zhu Y; Man Q; Jiang S; Lu L
    Emerg Microbes Infect; 2023 Dec; 12(1):2178241. PubMed ID: 36748716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
    Saito A; Irie T; Suzuki R; Maemura T; Nasser H; Uriu K; Kosugi Y; Shirakawa K; Sadamasu K; Kimura I; Ito J; Wu J; Iwatsuki-Horimoto K; Ito M; Yamayoshi S; Loeber S; Tsuda M; Wang L; Ozono S; Butlertanaka EP; Tanaka YL; Shimizu R; Shimizu K; Yoshimatsu K; Kawabata R; Sakaguchi T; Tokunaga K; Yoshida I; Asakura H; Nagashima M; Kazuma Y; Nomura R; Horisawa Y; Yoshimura K; Takaori-Kondo A; Imai M; ; Tanaka S; Nakagawa S; Ikeda T; Fukuhara T; Kawaoka Y; Sato K
    Nature; 2022 Feb; 602(7896):300-306. PubMed ID: 34823256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.